Creating a world where
Cancer Can’t Hide.
Cancer wins when it hides. Remaining undetected, cancer poses one of the greatest threats to life. When cancer wins, we all lose. But what if cancer couldn’t hide? What if there was a way to expose where it may be hiding and when it’s going to make its move?
Breast cancer has finally met its match.
Know where cancer may be hiding and when it might make its move.
Precise, powerful, proven
In the last five years alone, iCAD estimates reading more than 40 million mammograms worldwide, of which nearly 30% are tomosynthesis.
As soon as we implemented ProFound AI, we started using it on all of our DBT breast cancer screenings. It greatly improved our workflow and enabled us to get back to rapid reads and offered the opportunity to provide results for patients in real-time.Lisa Sheppard
MD, PINK Breast Center
After comparing all available options, we felt that iCAD’s technology was simply the best. We needed an AI solution that would allow us to read mammograms from either the Hologic workstation or from the Intelerad® PACS. ProFound AI, which supports multiple output formats, was able to provide that flexibility.Matt Dewey
Chief Information Officer, Wake Radiology
We decided to adopt ProFound AI because we felt it was the best product available to provide valid CAD markers on DBT. We also found iCAD’s other breast AI solutions enticing, such as PowerLook Density Assessment and ProFound AI Risk, as technologies we would like to assess.Arnold B. Honick
MD, Diagnostic Radiology Specialist at RCI
Proud to work with leading industry, research, technology, and advocacy partners.
GE HealthCare integrates iCAD ProFound into new breast cancer detection offering
- November 29, 2023
RSNA23: iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI
- November 29, 2023
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
- November 28, 2023
NASHUA, N.H., Nov. 28, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence (AI) powered solutions from iCAD’s ProFound Breast Health Suite are the first applications to be offered in GE HealthCare’s new MyBreastAI Suite* offering. As breast…
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
- November 27, 2023
NASHUA, N.H. – Nov. 27, 2023 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, will present new studies validating its artificial intelligence (AI) powered ProFound Breast Health Suite for uncovering hidden heart or vascular disease and predicting a woman’s risk for developing breast cancer…
From Pixels to Practice: Harnessing Innovations in Breast AI to Improve Patient Outcomes
- Dec 13, 2023
Dr. Emily Conant, Professor of Radiology and Vice Chair of Faculty Development in the Department of Radiology at the University of Pennsylvania, Perelman School of Medicine
Symposium, JFR21 Intelligence artificielle pour le cancer du sein : révolution actuelle et future pour un meilleur dépistage
- Oct 14, 2023
Samedi 8 octobre Le Pr Bruno Boyer, CIMI, Paris explique le rôle et l’impact clinique de l’utilisation des solutions d’intelligence artificielle d’iCAD en pratique quotidienne à travers des exemples de cas cliniques et le Pr Corinne Balleyguier de l’Institut Gustave Roussy présente les résultats d’études cliniques montrant les performances des…
Revolutionary Advancements in Mammography AI: Lifesaving Breakthroughs
- October 2, 2023
Every October, we shine a spotlight on breast cancer during National Breast Cancer Awareness Month. Thanks to the remarkable innovations in AI (Artificial Intelligence), we have more reasons to raise awareness about advancements in mammography than ever before. AI-powered mammography is revolutionizing care for patients’ breast health by finding cancers…
Embracing Clarity: Celebrating the 2nd Annual World Dense Breast Day
- September 27, 2023
At iCAD, we are recognizing the 2nd annual World Dense Breast Day today, a day that holds significant importance, not only for the women who may have dense breasts but for all of us dedicated to advancing breast health awareness and early cancer detection. As we gather to mark this…
ProFound Insights, ProFound Impact: How Cleveland Clinic is Finding the Breast Cancers Radiologists Fear the Most
- Jul 20, 2023
Thursday, July 20, 2023 While radiologists are trained experts in detecting breast cancer, certain types of tumors are still difficult to detect due to their elusive nature. Join us for a compelling discussion with Dr. Laura Dean, a renowned breast radiologist at the Cleveland Clinic, who will share how iCAD’s…
1. Mikael Eriksson et al. A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care. Sci. Transl. Med. 14, eabn3971 (2022). DOI: 10.1126/scitranslmed.abn3971. 2. Eriksson M, Czene K, Strand F, Zackrisson S, Lindholm P, Lång K, Förnvik D, Sartor H, Mavaddat N, Easton D, Hall P. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening. Radiology. 2020 Nov;297(2):327-333. doi: 10.1148/radiol.2020201620. Epub 2020 Sep 8. PMID: 32897160. 3. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm. Accessed 1-20-23. FDA 510K submissions K182373 (iCAD), K201019 (Hologic) and K193229 (ScreenPoint). 4. Conant EF, Toledano AY, Periaswamy S, Fotin SV, Go J, Boatsman JE, Hoffmeister JW. Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiol Artif Intell. 2019 Jul 31;1(4):e180096. doi: 10.1148/ryai.2019180096. PMID: 32076660; PMCID: PMC6677281. 5. https://www.nationalbreastcancer.org/early-detection-of-breast-cancer. Accessed 11-01-2023. 6. Lynge E, Vejborg I, Lillholm M, Nielsen M, Napolitano G, von Euler-Chelpin M. Breast density and risk of breast cancer. Int J Cancer. 2023 Mar 15;152(6):1150-1158. doi: 10.1002/ijc.34316. Epub 2022 Oct 27. PMID: 36214783; PMCID: PMC10091988.
iCAD data on file. Standalone performance varies by vendor.